Kappa Bioscience Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 47
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 4
  • Investments
  • 2

Kappa Bioscience General Information

Description

Producer of vitamin K2 intended to make it available to everybody and everywhere. The company follows a traditional vitamin production process with propriety and new steps with vitamin K2 as pure MK-7 in various formulations that be used in conventional foods, enabling customers to get pure, reliable, safe and stable forms of products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Silurveien 2
  • Building B
  • 0380 Oslo
  • Norway
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kappa Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kappa Bioscience‘s full profile, request access.

Request a free trial

Kappa Bioscience Executive Team (8)

Name Title Board Seat Contact Info
Egil Greve Chief Executive Officer & President
Peter Wisler Director Global Distributors Management
Inger Reidun Aukrust Ph.D Founder & Vice President, Research & Development & Chemistry
Kai Schröder Vice President, Finance and Operations
Jörg Büttinghaus Vice President, Sales & Marketing
You’re viewing 5 of 8 executive team members. Get the full list »

Kappa Bioscience Board Members (4)

Name Representing Role Since
000000 00000 000 Self Board Member 000 0000
000 0000000 Kappa Bioscience Board Member 000 0000
000000 000000 Self Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Kappa Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kappa Bioscience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kappa Bioscience‘s full profile, request access.

Request a free trial

Kappa Bioscience Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 28-May-2020 000000000 00000000 00.000 Drug Discovery
ppm.Ingredients 24-Jan-2017 Merger/Acquisition Distributors/Wholesale (B2C) 0000 00000
To view Kappa Bioscience’s complete investments and acquisitions history, request access »